Literature DB >> 9409682

maelstrom is required for an early step in the establishment of Drosophila oocyte polarity: posterior localization of grk mRNA.

N J Clegg1, D M Frost, M K Larkin, L Subrahmanyan, Z Bryant, H Ruohola-Baker.   

Abstract

We describe a mutant, maelstrom, that disrupts a previously unobserved step in mRNA localization within the early oocyte, distinct from nurse-cell-to-oocyte RNA transport. Mutations in maelstrom disturb the localization of mRNAs for Gurken (a ligand for the Drosophila Egf receptor), Oskar and Bicoid at the posterior of the developing (stage 3-6) oocyte. maelstrom mutants display phenotypes detected in gurken loss-of-function mutants: posterior follicle cells with anterior cell fates, bicoid mRNA localization at both poles of the stage 8 oocyte and ventralization of the eggshell. These data are consistent with the suggestion that early posterior localization of gurken mRNA is essential for activation of the Egf receptor pathway in posterior follicle cells. Posterior localization of mRNA in stage 3-6 oocytes could therefore be one of the earliest known steps in the establishment of oocyte polarity. The maelstrom gene encodes a novel protein that has a punctate distribution in the cytoplasm of the nurse cells and the oocyte until the protein disappears in stage 7 of oogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409682     DOI: 10.1242/dev.124.22.4661

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  34 in total

Review 1.  The developmental origins of the mammalian ovarian reserve.

Authors:  Kathryn J Grive; Richard N Freiman
Journal:  Development       Date:  2015-08-01       Impact factor: 6.868

Review 2.  Symmetry breaking during Drosophila oogenesis.

Authors:  Siegfried Roth; Jeremy A Lynch
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

3.  Expression of MAEL in nuage and non-nuage compartments of rat spermatogenic cells and colocalization with DDX4, DDX25 and MIWI.

Authors:  Miki Takebe; Yuko Onohara; Sadaki Yokota
Journal:  Histochem Cell Biol       Date:  2013-02-15       Impact factor: 4.304

4.  An in vivo RNAi assay identifies major genetic and cellular requirements for primary piRNA biogenesis in Drosophila.

Authors:  Daniel Olivieri; Martina M Sykora; Ravi Sachidanandam; Karl Mechtler; Julius Brennecke
Journal:  EMBO J       Date:  2010-09-03       Impact factor: 11.598

5.  Dynein and the actin cytoskeleton control kinesin-driven cytoplasmic streaming in Drosophila oocytes.

Authors:  Laura R Serbus; Byeong-Jik Cha; William E Theurkauf; William M Saxton
Journal:  Development       Date:  2005-08       Impact factor: 6.868

6.  A descent into the nuage: the maelstrom of transposon control.

Authors:  Kathryn A O'Donnell; Kathleen H Burns; Jef D Boeke
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

7.  Mouse maelstrom, a component of nuage, is essential for spermatogenesis and transposon repression in meiosis.

Authors:  Sarah F C Soper; Godfried W van der Heijden; Tara C Hardiman; Mary Goodheart; Sandra L Martin; Peter de Boer; Alex Bortvin
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

8.  Identification of a novel human cancer/testis gene MAEL that is regulated by DNA methylation.

Authors:  Ling Xiao; Yijun Wang; Yankai Zhou; Yi Sun; Wei Sun; Lin Wang; Chang Zhou; Jianlin Zhou; Jian Zhang
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

9.  Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.

Authors:  X-D Li; J-X Zhang; L-J Jiang; F-W Wang; L-L Liu; Y-J Liao; X-H Jin; W-H Chen; X Chen; S-J Guo; F-J Zhou; Y-X Zeng; X-Y Guan; Z-W Liu; D Xie
Journal:  Oncogene       Date:  2016-05-16       Impact factor: 9.867

10.  Retrotransposon silencing by piRNAs: ping-pong players mark their sub-cellular boundaries.

Authors:  Shinichiro Chuma; Ramesh S Pillai
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.